Hello! @AlisonSBarrett@twitter.com is in the editor's chair this week.
We're covering a range of issues including #VicVotesHealth2022, long COVID submissions, #HealthyCOP27 and more.

Read this thread to catch up on discussions from #SydneyID2022.

https://twitter.com/CroakeyNews/status/1597048245687291904

RT @CroakeyNews@twitter.com

Great discussions at this morning's sessions at #SydneyID2022 @Sydney_ID@twitter.com

Following is a thread of threads... https://twitter.com/JocelyneBasseal/status/1597043950225063936

The final session of #SydneyID2022 included a discussion about the challenging research funding landscape & suggestions for collaboration & diversifying funding sources.

Final thread👇

https://twitter.com/CroakeyNews/status/1597062841365762048

Prof @michaelKassiou@twitter.com wraps up the panel discussion with key takeaways = collaboration and importance of thinking about the end before you start #SydneyID2022

@MedResearchNSW@twitter.com can also provide options for in-kind support for International projects & grants if they align with NSW values and strategies
#SydneyID2022

A cont – Also important to consider the risk of relying on funds from one source (ie if their funding runs out) – Grimes #SydneyID2022

Q from audience – thought about opening up where funding comes from to a more stable source?
A – bound by who we can accept money from, every donor has to go through an ethics process, some won't "cut the muster". #SydneyID2022

@wellcometrust@twitter.com an example of global charitable foundation - they're not as bound by funding calendars like NHMRC
#SydneyID2022

Questions to consider: If you weren't funded, why should it matter, who would care, who would notice? – @MichaelKassiou@twitter.com #SydneyID2022

In philanthropic proposals, important to frame what the problem is, the solution your research will form part of, & the impact that will be generated
– Grimes #SydneyID2022

Philanthropy is more flexible than other types of funding, not tied to particular schemes, but philanthropy interest.

Brings freedom & flexibility, but may be limited in duration (ie difficult to fund clinical trials with philanthropy) – Grimes #SydneyID2022

One of failures in drug-discovery is the difficulties in being able to progress things – @MichaelKassiou@twitter.com #SydneyID2022

What are the key priorities for @MedResearchNSW@twitter.com going forward?
A from Penna – a number of programs already set. Short-term future looks to be in advanced therapeutics (targeted, personalised) & clinical trial, and use of real-time data #SydneyID2022

Mentorship is one way to engage & build early relationships with industry
– Swemmer #SydneyID2022

There is an exception to do more innovation with less.
– Swemmer #SydneyID2022

How do you make yourself visible to an industry partner?
A from Swemmer – be strategic, who's aligned with your areas of research?, be ready before the opportunity knocks on the door.
Build the relationship over time.
#SydneyID2022

From a philanthropy angle, there is absolutely not enough funding to go around.
Philanthropic funding should leverage off NHMRC etc funding, smooth out the end-to-end funding process.
Be creative & diversify approach to funding
– Grimes #SydneyID2022

We have to be funder-ready. Need a track record to show how you work together. Should be a lot more proactive and organised.
– Penna #SydneyID2022

Diversification of funding sources (ie to philanthropy etc)
Collaboration a key factor for diversifying
#SydneyID2022

From an Australian perspective, there is a scope to increase research funding flow towards Australia

Be investor-ready. Consider collaborations.
– Swemmer #SydneyID2022

We have to access different funding sources – look for global solutions from global funding schemes.
But, there is never enough funding, despite there being many research ideas and need.
– @DanielleLSomers@twitter.com #SydneyID2022